Compugen Ltd
Symbol: CGEN (NASDAQ)
1.45
▲ (8.65%) 0.115
Company Description:
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
Key Stats
- Today's Open: $1.34
- Today's High: $1.465
- Today's Low: $1.29
- Today's Volume: 535.26K
- Yesterday Close: $1.33
- Yesterday High: $1.37
- Yesterday Low: $1.32
- Yesterday Volume: 258.28K
- Last Min Volume: 15
- Last Min High: $1.445
- Last Min Low: $1.445
- Last Min VWAP: $1.445
Company Profile
- Name: Compugen Ltd
- Website: https://www.cgen.com
- Listed Date: 2000-08-11
- Location: ,
- Market Status: Active
- CIK Number: 0001119774
- SIC Code:
- SIC description:
- Market Cap: $124.40M
- Round Lot: 100
- Outstanding Shares: 93.54M
- Asset Type: CS
RECENT FILINGS FOR CGEN
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-17 | 6-K | View |
| 2025-08-06 | 6-K | View |
| 2025-08-06 | 6-K | View |
| 2025-07-21 | 6-K | View |
| 2025-05-19 | 6-K | View |
| 2025-05-13 | 6-K | View |
| 2025-03-04 | 20-F | View |
| 2025-03-04 | 6-K | View |
| 2025-02-14 | SCHEDULE 13G/A | View |
| 2025-01-08 | 6-K | View |
| 2024-11-27 | 6-K | View |
| 2024-11-12 | 6-K | View |
| 2024-11-05 | 6-K | View |
| 2024-09-13 | 6-K | View |
| 2024-08-06 | 6-K | View |
| 2024-08-05 | 6-K | View |
| 2024-07-29 | 6-K | View |
| 2024-05-30 | 6-K | View |
| 2024-05-20 | 6-K | View |
| 2024-05-15 | 6-K | View |
Latest News on CGEN